Form 4 for RGEN REPLIGEN CORP
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0000899243-22-010327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-09 | 2022-03-08 | RGEN | Snodgres Jon | CFO | M - OptEx | $41.34 | +4,166 | 38.7K | +12% | +$172.2K |
| DM | 2022-03-09 | 2022-03-08 | RGEN | Snodgres Jon | CFO | M - OptEx | $0.00 | +4,166 | 13.7K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-08 | M | A | 1,214 | $59.52 | 39,899 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-08 | M | A | 2,952 | $33.87 | 38,685 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | M | A | 1,214 | $0.00 | 2,574 | D | $59.52 · — to 2029-02-28 | 1,214 Common Stock | (F1) This option is currently exercisable. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | M | A | 2,952 | $0.00 | 13,707 | D | $33.87 · — to 2028-03-01 | 2,952 Common Stock | (F1) This option is currently exercisable. |